A detailed history of Acadian Asset Management LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 5,169 shares of MEDP stock, worth $1.81 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,169
Previous 10,570 51.1%
Holding current value
$1.81 Million
Previous $4.35 Million 60.36%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$320.58 - $457.29 $1.73 Million - $2.47 Million
-5,401 Reduced 51.1%
5,169 $1.72 Million
Q2 2024

Aug 06, 2024

SELL
$372.0 - $424.34 $4.98 Million - $5.68 Million
-13,375 Reduced 55.86%
10,570 $4.35 Million
Q1 2024

May 10, 2024

SELL
$284.87 - $413.31 $8.98 Million - $13 Million
-31,514 Reduced 56.82%
23,945 $9.67 Million
Q4 2023

Feb 13, 2024

BUY
$227.52 - $312.68 $803,373 - $1.1 Million
3,531 Added 6.8%
55,459 $17 Million
Q3 2023

Nov 13, 2023

SELL
$233.98 - $281.67 $5.58 Million - $6.71 Million
-23,839 Reduced 31.46%
51,928 $12.6 Million
Q2 2023

Aug 07, 2023

SELL
$187.26 - $240.17 $10.6 Million - $13.6 Million
-56,802 Reduced 42.85%
75,767 $18.2 Million
Q1 2023

May 11, 2023

BUY
$174.31 - $239.52 $437,518 - $601,195
2,510 Added 1.93%
132,569 $24.9 Million
Q4 2022

Feb 14, 2023

BUY
$153.06 - $226.57 $19.6 Million - $29 Million
128,060 Added 6406.2%
130,059 $27.6 Million
Q3 2022

Nov 14, 2022

BUY
$145.13 - $182.49 $290,114 - $364,797
1,999 New
1,999 $313,000
Q3 2022

Nov 14, 2022

BUY
$145.13 - $182.49 $290,114 - $364,797
1,999 New
1,999 $313,000
Q1 2022

May 12, 2022

SELL
$138.87 - $214.31 $434,524 - $670,575
-3,129 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$170.18 - $198.21 $1.78 Million - $2.08 Million
-10,471 Reduced 76.99%
3,129 $592,000
Q2 2021

Aug 11, 2021

SELL
$158.62 - $194.3 $18.3 Million - $22.5 Million
-115,671 Reduced 89.48%
13,600 $2.4 Million
Q1 2021

May 11, 2021

SELL
$132.02 - $168.26 $6.8 Million - $8.67 Million
-51,515 Reduced 28.5%
129,271 $21.2 Million
Q4 2020

Feb 11, 2021

SELL
$109.38 - $149.19 $5.65 Million - $7.71 Million
-51,652 Reduced 22.22%
180,786 $25.2 Million
Q3 2020

Nov 09, 2020

SELL
$92.95 - $130.61 $14.7 Million - $20.7 Million
-158,607 Reduced 40.56%
232,438 $26 Million
Q2 2020

Aug 12, 2020

SELL
$68.08 - $95.68 $4.88 Million - $6.86 Million
-71,647 Reduced 15.48%
391,045 $36.4 Million
Q1 2020

May 11, 2020

SELL
$61.71 - $101.95 $4.16 Million - $6.87 Million
-67,365 Reduced 12.71%
462,692 $34 Million
Q4 2019

Feb 06, 2020

SELL
$70.08 - $84.64 $44.6 Million - $53.9 Million
-636,950 Reduced 54.58%
530,057 $44.6 Million
Q3 2019

Nov 07, 2019

SELL
$62.38 - $85.89 $4.36 Million - $6 Million
-69,893 Reduced 5.65%
1,167,007 $98.1 Million
Q2 2019

Aug 08, 2019

SELL
$53.64 - $65.42 $2.62 Million - $3.19 Million
-48,777 Reduced 3.79%
1,236,900 $80.9 Million
Q1 2019

May 09, 2019

SELL
$49.38 - $70.58 $3.46 Million - $4.94 Million
-69,974 Reduced 5.16%
1,285,677 $75.8 Million
Q4 2018

Feb 07, 2019

SELL
$46.97 - $63.98 $5.09 Million - $6.94 Million
-108,470 Reduced 7.41%
1,355,651 $71.8 Million
Q3 2018

Oct 30, 2018

BUY
$43.25 - $63.74 $7.9 Million - $11.6 Million
182,588 Added 14.25%
1,464,121 $87.7 Million
Q2 2018

Jul 24, 2018

BUY
$34.03 - $45.46 $9.6 Million - $12.8 Million
282,216 Added 28.24%
1,281,533 $55.1 Million
Q1 2018

Apr 12, 2018

BUY
$32.03 - $39.05 $11.7 Million - $14.3 Million
365,574 Added 57.68%
999,317 $34.9 Million
Q4 2017

Jan 18, 2018

BUY
$32.46 - $38.31 $1.33 Million - $1.57 Million
40,944 Added 6.91%
633,743 $23 Million
Q3 2017

Oct 13, 2017

BUY
$27.43 - $33.11 $16.3 Million - $19.6 Million
592,799
592,799 $18.9 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.9B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.